Cargando…
The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine
The landscape of sarcoma care is on the cusp of a transformative era, spurred by the convergence of digital health and artificial intelligence (AI). This perspectives article explores the multifaceted opportunities and challenges in leveraging these technologies for value-based, precision sarcoma ca...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672685/ https://www.ncbi.nlm.nih.gov/pubmed/38003845 http://dx.doi.org/10.3390/jpm13111530 |
_version_ | 1785140449126645760 |
---|---|
author | Fuchs, Bruno Studer, Gabriela Bode-Lesniewska, Beata Heesen, Philip |
author_facet | Fuchs, Bruno Studer, Gabriela Bode-Lesniewska, Beata Heesen, Philip |
author_sort | Fuchs, Bruno |
collection | PubMed |
description | The landscape of sarcoma care is on the cusp of a transformative era, spurred by the convergence of digital health and artificial intelligence (AI). This perspectives article explores the multifaceted opportunities and challenges in leveraging these technologies for value-based, precision sarcoma care. We delineate the current state-of-the-art methodologies and technologies in sarcoma care and outline their practical implications for healthcare providers, administrators, and policymakers. The article also addresses the limitations of AI and digital health platforms, emphasizing the need for high-quality data and ethical considerations. We delineate the promise held by the synergy of digital health platforms and AI algorithms in enhancing data-driven decision-making, outcome analytics, and personalized treatment planning. The concept of a sarcoma digital twin serves as an illustrative paradigm for this integration, offering a comprehensive, patient-centric view of the healthcare journey. The paper concludes with proposals for future research aimed at advancing the field, including the need for randomized controlled trials or target trial emulations and studies focusing on ethical and economic aspects. While the road to this transformative care is laden with ethical, regulatory, and practical challenges, we believe that the potential benefits far outweigh the obstacles. We conclude with a call to action for multidisciplinary collaboration and systemic adoption of these technologies, underscoring the urgency to act now for the future betterment of sarcoma care and healthcare at large. |
format | Online Article Text |
id | pubmed-10672685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106726852023-10-25 The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine Fuchs, Bruno Studer, Gabriela Bode-Lesniewska, Beata Heesen, Philip J Pers Med Perspective The landscape of sarcoma care is on the cusp of a transformative era, spurred by the convergence of digital health and artificial intelligence (AI). This perspectives article explores the multifaceted opportunities and challenges in leveraging these technologies for value-based, precision sarcoma care. We delineate the current state-of-the-art methodologies and technologies in sarcoma care and outline their practical implications for healthcare providers, administrators, and policymakers. The article also addresses the limitations of AI and digital health platforms, emphasizing the need for high-quality data and ethical considerations. We delineate the promise held by the synergy of digital health platforms and AI algorithms in enhancing data-driven decision-making, outcome analytics, and personalized treatment planning. The concept of a sarcoma digital twin serves as an illustrative paradigm for this integration, offering a comprehensive, patient-centric view of the healthcare journey. The paper concludes with proposals for future research aimed at advancing the field, including the need for randomized controlled trials or target trial emulations and studies focusing on ethical and economic aspects. While the road to this transformative care is laden with ethical, regulatory, and practical challenges, we believe that the potential benefits far outweigh the obstacles. We conclude with a call to action for multidisciplinary collaboration and systemic adoption of these technologies, underscoring the urgency to act now for the future betterment of sarcoma care and healthcare at large. MDPI 2023-10-25 /pmc/articles/PMC10672685/ /pubmed/38003845 http://dx.doi.org/10.3390/jpm13111530 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Fuchs, Bruno Studer, Gabriela Bode-Lesniewska, Beata Heesen, Philip The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title | The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title_full | The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title_fullStr | The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title_full_unstemmed | The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title_short | The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine |
title_sort | next frontier in sarcoma care: digital health, ai, and the quest for precision medicine |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672685/ https://www.ncbi.nlm.nih.gov/pubmed/38003845 http://dx.doi.org/10.3390/jpm13111530 |
work_keys_str_mv | AT fuchsbruno thenextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT studergabriela thenextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT bodelesniewskabeata thenextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT heesenphilip thenextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT thenextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT fuchsbruno nextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT studergabriela nextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT bodelesniewskabeata nextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT heesenphilip nextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine AT nextfrontierinsarcomacaredigitalhealthaiandthequestforprecisionmedicine |